ReviewFrontiers in cardiovascular medicine2022

Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes.

Louise Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.